Skip to main
  1. Stocks
  2. Chiron Real Estate Inc
  3. Forecast
XRN

XRN Stock Forecast & Price Target

XRN Analyst Ratings

Based on 4 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Chiron Real Estate is supported by a compelling, self-funded transformation from lower-growth medical office assets into senior housing operating properties, a segment with strong demographic tailwinds from the aging Baby Boomer cohort and constrained new supply. Its 3Q26 results showed diluted Core FFO of $0.75 per share versus $0.84 estimated, while same-property cash NOI still rose 1.6% year over year and the outpatient medical portfolio remained 93.6% leased with a 74.4% NOI margin, underscoring durable underlying cash generation. Management has also strengthened liquidity and reduced risk with net debt to adjusted EBITDAre improving to 6.0x, no debt maturities until 2028, and executed asset sales and SHOP acquisitions that should support higher long-term growth and a narrower valuation discount as lease-up progresses.

Bears say

Chiron Real Estate is facing a fundamental growth stall as higher rates since 2022 compressed acquisition spreads, reduced external growth, and left its medical office portfolio with only 2.1% blended rent escalators and a 4.4-year WALT, making organic expansion modest. Management’s shift from OMF into SHOP at a roughly 50 bps negative initial investment yield spread, along with slower lease-up at The Riviera and Pinnacle, has driven down normalized FAD estimates to $2.64 and $1.16 for 2026 and 2027, with $2.40 per share initiated for 2028. Despite near-full occupancy and a durable healthcare tenant base, the company’s small scale, limited $3mm-$4mm daily trading liquidity, and concentration in a few states heighten execution and investor-access risks.

XRN has been analyzed by 4 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Chiron Real Estate Inc and is not a guaranteed prediction by Public.com or investment advice.

XRN Analyst Forecast & Price Prediction

Get the latest XRN stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in XRN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Chiron Real Estate Inc (XRN) Forecast

Analysts have given XRN a Hold based on their latest research and market trends.

According to 4 analysts, XRN has a Hold consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $39, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $39, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Chiron Real Estate Inc (XRN)


XRN Analyst Forecast & Price Prediction

Get the latest XRN stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in XRN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover XRN stock data and trends